Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-ray repair cross-complementing protein 3 (XRCC3) is a member of the RecA/Rad51-related protein family that is essential for the homologous recombination repair (HRR) pathway of double-stranded DNA, promoting chromosomal stability by repairing DNA damage such as chromosomal fragmentation, translocations, and deletions. XRCC3 acts as a partner within protein complexes (notably, the RAD51 paralog complexes) involved in late stages of homologous recombination, including processing Holliday junctions and maintaining genome integrity. Genetic variations in XRCC3 are associated with altered cancer susceptibility and radiosensitivity. Key distinctions: - XRCC3 is distinct from XRCC1, another DNA repair protein, and is primarily involved in homologous recombination, not single-strand break repair. - There are currently no drugs that directly target XRCC3, but its status in HR pathways makes it relevant to synthetic lethality strategies in cancer therapy.
Not typically a direct drug target, but drugs targeting homologous recombination and DNA repair pathways may indirectly affect XRCC3 function (e.g., synthetic lethality with PARP inhibitors in HR-deficient cancers)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray repair cross-complementing protein 3 (XRCC3).